Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 16, 2026

Defiance ETFs Mengumumkan Penyambungan Semula Dagangan bagi Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc.

View original at globenewswire.com
Defiance ETFs Mengumumkan Penyambungan Semula Dagangan bagi Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc. MIAMI, June 17, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs, peneraju dalam dana dagangan bursa bertema dan berleveraj, hari ini mengumumkan bahawa Cboe BZX Exchange, Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • For periods longer than one day, the fund's performance will be the result of compounded daily returns, which will almost certainly differ from 200% of the Target Portfolio's return over the same period

    60% confidence
  • The derivatives market (swaps, options) for SpaceX as a newly listed company may be limited, illiquid, highly volatile, expensive, or unavailable, which could increase tracking error or prevent the fund from achieving its investment objective

    60% confidence
  • SpaceX is expected to be a controlled company with voting power concentrated in founder Elon Musk through Class B common shares carrying 10 votes per share

    60% confidence
  • An investor could lose the entire value of their principal investment in a single trading day

    60% confidence
  • The SpaceX IPO constitutes a Material Space Event as defined in the amended Prospectus, which will cause the fund to hold all or a significant portion of its portfolio in instruments providing exposure to SpaceX shares

    60% confidence
  • The fund is intended for knowledgeable investors who understand the implications of seeking leveraged daily (2X) investment results and are prepared to monitor their portfolios frequently; it is not suitable for investors who do not intend to actively monitor and manage their portfolios

    60% confidence
  • The fund's investment results following a rebalancing in response to a Material Space Event may differ materially from prior results, and the fund may temporarily deviate from its targeted daily exposure level

    60% confidence
  • Cboe BZX Exchange has approved the resumption of trading in SPCL shares following the temporary suspension initiated by the Exchange on June 12, 2026

    60% confidence
  • Throughout the suspension period, the underlying portfolio assets remained secure and were unaffected by the trading suspension imposed by the Exchange

    60% confidence
  • Defiance pioneered single-stock leveraged ETFs, allowing investors to take amplified positions in high-potential companies with precise leveraged exposure without opening a margin account

    60% confidence
  • SPCL's investment in SpaceX exposure relies on derivatives (swap agreements and listed option contracts) rather than directly holding underlying securities

    60% confidence
  • SPCL seeks daily investment results equal to 200% of the daily performance of its Target Portfolio

    60% confidence
  • SpaceX risks include new or unproven technology programs such as Starship, next-generation Starlink satellites, and orbital AI initiatives

    60% confidence

Data points we hold from this source

Elon Musk · parameter count10 votes_per_Class_B_share
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Defiance ETFs Mengumumkan Penyambungan Semula Dagangan bagi Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc. — Source | Via News | ViaNews Market